FGP
MET icon

Freestone Grove Partners’s MetLife MET Stock Holding History

Freestone Grove Partners’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-600,966
Closed -$48.3M – 787
2025
Q1 		$48.3M Buy
600,966
+441,952
+278% +$36.8M 0.5% 64
2024
Q4 		$13M Buy
+159,014
New +$13.2M 0.16% 177

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Freestone Grove Partners's MET Position: Q2 2025 in Review

Freestone Grove Partners sold out of MetLife (MET) in Q2 2025, closing a stake of 600,966 shares — an estimated $48.3M sold.

Freestone Grove Partners first reported a position in MET in Q4 2024 and held it in 2 quarters. The position peaked at $48.3M in Q1 2025. 1,410 funds tracked by Wall St. Rank hold MET as of Q2 2025.

  • Freestone Grove Partners reported no remaining MetLife position as of Q2 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 600,966 MetLife shares in Q2 2025, an estimated $48.3M.
  • Freestone Grove Partners first reported a position in MetLife in Q4 2024 and held it in 2 quarters.
  • Freestone Grove Partners's MetLife position peaked at $48.3M in Q1 2025.
  • 1,410 funds tracked by Wall St. Rank held MetLife as of Q2 2025.

Based on Freestone Grove Partners's 13F filing for Q2 2025, filed 14 Aug 2025.